{"canonical":"https://abierto.us/vendors/microbiotix-inc-scnkbdm341t1","key":"SCNKBDM341T1","name":"MICROBIOTIX, INC.","uei":"SCNKBDM341T1","city":"WORCESTER","state":"MA","awards":2,"obligated":"3787586.00","notices_won":0,"top_agency_name":"National Institutes of Health","top_naics":"541715","cage":"465F8","parent_name":"MICROBIOTIX, INC.","also_known_as":[],"country":"USA","actions":4,"first_action":"2026-06-18","last_action":"2026-08-26","breakdowns":{"naics":[{"key":"541715","name":null,"awards":2,"obligated":"3787586.00"}],"places":[{"key":"MA","name":null,"awards":2,"obligated":"3787586.00"}],"agencies":[{"key":"7529","name":"National Institutes of Health","awards":2,"obligated":"3787586.00"}],"award_types":[{"key":"DEFINITIVE CONTRACT","name":null,"awards":2,"obligated":"3787586.00"}],"competition":[{"key":"FULL AND OPEN COMPETITION","name":null,"awards":2,"obligated":"3787586.00"}],"product_service_codes":[{"key":"AN12","name":null,"awards":2,"obligated":"3787586.00"}]},"awards_list":[{"award_key":"CONT_AWD_75N93023C00001_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N93023C00001_7529_-NONE-_-NONE-/","piid":"75N93023C00001","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"SCNKBDM341T1","recipient_name":"MICROBIOTIX, INC.","recipient_uei":"SCNKBDM341T1","recipient_cage":"465F8","recipient_city":"WORCESTER","recipient_state":"MA","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIAID","office_key":"o-75N930","first_action_date":"2026-07-09","last_action_date":"2026-08-21","actions":2,"obligated":"3787586.00","current_total_value":"8795790.00","potential_total_value":"14195727.00","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":10,"description":"EO14398 TO DEVELOP THE PPZ SERIES OF SMALL MOLECULE PAN-FILOVIRUS ENTRY INHIBITORS THROUGH LEAD OPTIMIZATION, SELECTION OF A PRECLINICAL CANDIDATE, AND IND-ENABLING PRECLINICAL STUDIES.","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_75N93020C00019_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N93020C00019_7529_-NONE-_-NONE-/","piid":"75N93020C00019","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"SCNKBDM341T1","recipient_name":"MICROBIOTIX, INC.","recipient_uei":"SCNKBDM341T1","recipient_cage":"465F8","recipient_city":"WORCESTER","recipient_state":"MA","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIAID","office_key":"o-75N930","first_action_date":"2026-06-18","last_action_date":"2026-08-26","actions":2,"obligated":"0","current_total_value":"7263391.00","potential_total_value":"7621277.00","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":12,"description":"TO DEVELOP PHENOXYACETAMIDE T3SS INHIBITORS AS ADJUNCTIVE AGENTS TO ANTIBACTERIAL THERAPY FOR MDR P. AERUGINOSA INFECTIONS.","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":2,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}